Alpelisib 300mg Film-Coated Tablets $120

Alpelisib is a PI3K inhibitor. It’s used to treat breast cancer in people with HR and HER2- mutations, and who have PIK3CA changes. It works by focusing on the PI3K signaling pathway.

You’ve got these dosages: 50, 200, and 300 mg, all in these coated tablets. The usual go-to is 300 mg once a day, and you should take it with some food. They come in packs with 28 tablets each.

The way they’re set up with different strengths and those blister packs makes it easy and flexible for patients. Stopping the PI3K pathway with this med might help fight cancer cell growth, especially in cases with PIK3CA mutations. Health care providers really need to think about how well it works and how safe it is when they’re picking a treatment for this kind of breast cancer.